Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2012

4261 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Aripiprazole Therapy and CYP2D6 Genotype

Dean L, Kane M.

2016 Sep 22 [updated 2021 Feb 10]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Xanthine Derivatives

2020 Jul 18. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

0

0

0

PUBMED

Atomoxetine Therapy and CYP2D6 Genotype

Dean L.

2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Drug-induced movement disorders: emergencies and management.

Robottom BJ, Shulman LM, Weiner WJ.

Neurol Clin. 2012 Feb;30(1):309-20, x. doi: 10.1016/j.ncl.2011.09.007. Review.

0

0

0

PUBMED

Functional brain networks and abnormal connectivity in the movement disorders.

Poston KL, Eidelberg D.

Neuroimage. 2012 Oct 1;62(4):2261-70. doi: 10.1016/j.neuroimage.2011.12.021. Review.

0

0

0

PUBMED

Sleep-related movement disorders.

Merlino G, Gigli GL.

Neurol Sci. 2012 Jun;33(3):491-513. doi: 10.1007/s10072-011-0905-9. Review.

0

0

0

PUBMED

Psychogenic movement disorders in children: characteristics and predictors of outcome.

Faust J, Soman TB.

J Child Neurol. 2012 May;27(5):610-4. doi: 10.1177/0883073811422753.

0

0

0

PUBMED

Effectiveness of an inpatient movement disorders program for patients with atypical parkinsonism.

Hohler AD, Tsao JM, Katz DI, Dipiero TJ, Hehl CL, Leonard A, Allen V, Gardner M, Phenix H, Saint-Hilaire M, Ellis T.

Parkinsons Dis. 2012;2012:871974. doi: 10.1155/2012/871974.

0

0

0

PUBMED

Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.

Kulisevsky J, Poyurovsky M.

Eur Neurol. 2012;67(1):4-11. doi: 10.1159/000331768. Review.

0

0

0

PUBMED

Movement disorders in patients with diabetes mellitus.

Jagota P, Bhidayasiri R, Lang AE.

J Neurol Sci. 2012 Mar 15;314(1-2):5-11. doi: 10.1016/j.jns.2011.10.033. Review.

0

0

0

PUBMED

Occurrence of eye movement disorders in motor neuron disease.

Beaufils E, Corcia P, de Toffol B, Praline J.

Amyotroph Lateral Scler. 2012 Jan;13(1):84-6. doi: 10.3109/17482968.2011.580848.

0

0

0

PUBMED

Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol.

Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE.

Parkinsonism Relat Disord. 2012 Mar;18(3):247-51. doi: 10.1016/j.parkreldis.2011.10.011.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy